AccuStem Sciences, Inc. (ACUT)
OTCMKTS · Delayed Price · Currency is USD
1.910
-0.070 (-3.54%)
At close: Aug 29, 2025
AccuStem Sciences Market Cap
AccuStem Sciences has a market cap or net worth of $30.70 million as of August 29, 2025. Its market cap has increased by 499.76% in one year.
Market Cap
30.70M
Enterprise Value
30.73M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.91
Market Cap Chart
Since March 2, 2022, AccuStem Sciences's market cap has increased from 20.42M to 30.70M, an increase of 50.34%. That is a compound annual growth rate of 12.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 29, 2025 | 30.70M | 503.91% |
| Dec 31, 2024 | 5.08M | -28.40% |
| Dec 29, 2023 | 7.10M | -53.62% |
| Dec 30, 2022 | 15.31M | -25.04% |
| Mar 2, 2022 | 20.42M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.42M |
| Veradigm | 832.17M |
| Elite Pharmaceuticals | 734.61M |
| Tian'an Technology Group | 682.77M |
| Glass House Brands | 655.63M |
| Northwest Biotherapeutics | 448.50M |
| CytoDyn | 376.00M |
| American Oncology Network | 343.87M |